Pfizer, marking fast research pace, starts key trial of RSV vaccine
Bio Pharma Dive
SEPTEMBER 2, 2021
The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.
UK Pharma Company Scancell Selects COVID-19 Vaccine for Clinical Trials | 2020-12-21
The Pharma Data
DECEMBER 20, 2020
UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Will people line up for a COVID-19 vaccine?
World of DTC Marketing
AUGUST 3, 2020
QUICK READ: As COVID-19 vaccines enter Phase III trials one has to wonder just how transparent pharma companies will be with the data. Personally I would want to know as much as I can before I ask for the vaccine but I also know that greed can make people do stupid things and there is a lot of money at stake here.
Vaccination 
155
155 
UK Vaccine Taskforce head lifts lid on Novavax deal
pharmaphorum
APRIL 19, 2021
The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS. Speed is everything in clinical development.
Vaccination 141
141 
Researchers Urge Greater Transparency for Government-Funded Vaccine Trials
The Pharma Data
OCTOBER 21, 2020
More than two dozen researchers and experts have penned a letter to HHS Secretary Alex Azar, National Institutes of Health (NIH) officials and pharma company executives, imploring them to shed more light on the clinical trial designs for federally funded COVID-19 vaccine studies. Source link.
Vaccination 52
52 
Cancer vaccines: providing the edge in oncology
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.
Vaccination 129
129 
Pfizer’s seeks silver lining in failed C. diff vaccine trial
pharmaphorum
MARCH 2, 2022
Pfizer’s vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a phase 3 trial. With no approved vaccines to date, C. The only other company with a C. First, the bad news.
Vaccination 52
52 
Large pharma companies support Women in STEM leadership pilot
Drug Discovery World
DECEMBER 7, 2022
We are excited to open up the waitlist for the next stage, and encourage people from other backgrounds to get involved, including our tech company members.” . The programme is like a vaccine – we expose leaders to trial situations to understand the root causes of how inequality manifests in the workplace and to uncover unconscious biases.
So much for pharma earning trust back
World of DTC Marketing
NOVEMBER 27, 2020
SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided.
Vaccination 208
208 
AI continues to gain momentum in the biopharmaceutical industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.
Big Data 303
303 
Vaccines upstart Curevo has designs on blockbuster GSK franchise
pharmaphorum
FEBRUARY 14, 2022
Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. The cash will fund a phase 2b trial in 678 people aged over 50 that will compare CRV?101’s
Vaccination 52
52 
On Clinical Trials Day, CVS shares lessons learned from one year providing trial services
pharmaphorum
MAY 20, 2022
Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. This interview has been edited for length and clarity.
Can technology help diversify clinical trials?
pharmaphorum
MAY 27, 2022
This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.
Ultimovacs ASA Initiates FOCUS Phase II Trial for Universal Cancer Vaccine, UV1, in Head and Neck Cancer Patients Receiving Pembrolizumab
The Pharma Data
DECEMBER 21, 2020
The trial will be conducted at 10 sites across Germany and led by principal investigator Prof. The FOCUS trial is Ultimovacs’ fourth Phase II clinical trial with UV1 and comes in addition to the collaboration Phase II trial announced in May 2020. “We Mascha Binder, M.D.,
Trials 52
52 
Increasing patient engagement with UK clinical trials
pharmaphorum
FEBRUARY 11, 2021
Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. During the course of my treatments and my trials, and afterwards, I was the expert in how I wanted to manage my life.”.
In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player
Delveinsight
JULY 29, 2020
Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.
Vaccination 62
62 
Activist investor Elliott builds stake in GSK after fresh trial upset
pharmaphorum
APRIL 16, 2021
Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial results this year raised questions about management’s strategy to turn around the company’s fortunes. But that failed in a late-stage lung cancer trial comparing it with Keytruda in January.
Trials 69
69 
Earning trust and building trust need to occur at the same time
World of DTC Marketing
MARCH 1, 2021
Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. The employees at J&J are saying, on LinkedIn, how proud they are that their company developed a COVID vaccine. More support and improvement of processes are needed.
Vaccination 180
180 
Edelman Trust Barometer raises questions
World of DTC Marketing
MARCH 11, 2022
3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.
Pharma Companies 212
212 
HCP’s use of social media: the good and the not so good
World of DTC Marketing
AUGUST 9, 2021
86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.
Nurses 294
294 
Keeping tabs on Covid-19: UK approves safety of Pfizer and BioNTech’s Covid-19 vaccine
The Pharma Data
DECEMBER 4, 2020
After an incredible milestone for science, this week we bring our readers news from Pfizer and BioNTech on the promise of a Covid-19 vaccine result. Pfizer and BioNTech achieve first authorization use for their Covid-19 vaccine in the UK. Our aim is to bring a safe and effective vaccine upon approval to the people who need it.
Vaccination 52
52 
ESG Top Trends: Macroeconomic trends
Pharmaceutical Technology
JULY 21, 2022
In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. In response to the Ukraine crisis, many pharma companies are ensuring a supply of essential medicine to Ukraine and surrounding countries. Drug pricing and gouging.
Pharma Companies 130
130 
Deep Dive: Oncology 2022
pharmaphorum
JULY 7, 2022
As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Realising the promise of cancer vaccines. Phesi’s Dr Gen Li: new approaches to clinical trials in cancer. New horizons in breast cancer care.
Vaccination 52
52 
This week in drug discovery (11-15 September)
Drug Discovery World
SEPTEMBER 15, 2023
The headlines: Pharma must embrace an AI future says new report Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com.
Drugs 52
52 
Keeping tabs on Covid-19: A watershed moment for Pfizer and BioNTech as they announce Covid-19 vaccine is 90 per cent efficient
The Pharma Data
NOVEMBER 9, 2020
In a special edition Keeping tabs round-up, Pharma IQ features the ever-anticipated news of a possible Covid-19 cure. Pfizer and BioNTech announce Covid-19 vaccine candidate success. As the Phase 3 study continues, Pfizer and BioNTech claimed the final vaccine efficacy percentage may vary.
Vaccination 52
52 
On the pharma ecosystem
World of DTC Marketing
AUGUST 5, 2020
When the publics level of trust in pharma goes up and stays there that is the best award any company can receive. Moderna has received almost $1 billion in taxpayer grants to get its vaccine through clinical trials and is considering setting the highest price of all coronavirus vaccine candidates.
Vaccination 180
180 
Keeping tabs on Covid-19: Iceni Diagnostics creates new virus detection device and the RDIF announce its vaccine is more than 95 per cent efficient
The Pharma Data
NOVEMBER 27, 2020
Vaccine development to cure coronavirus is at an all-time high after Pfizer and BioNTech announced they had success with a possible vaccine candidate. One dose of the Sputnik V vaccine will cost less than $10 for international markets.
Vaccination 52
52 
Coronavirus pharma news round-up 21/08/20
pharmaphorum
AUGUST 21, 2020
New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandemic continues. The post Coronavirus pharma news round-up 21/08/20 appeared first on.
Vaccination 105
105 
Keeping tabs on Covid-19: Thermo Fisher Scientific antibody test is granted the CE Mark Certification and pharma cargo companies prepare for temperature-controlled vaccine delivery
The Pharma Data
DECEMBER 11, 2020
The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. 200 carrier pods acquired for increased demand of Covid-19 vaccine refrigerated storage. Thermo Fisher Scientific gains CE Mark Certification for its Covid-19 test.
Antibody 52
52 
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech’s COVID Vaccine; Alexion buyout; the debut of InnoSkel
Delveinsight
DECEMBER 15, 2020
Gannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-alcoholic steatohepatitis (NASH). The FTA designation will help the pharma company to advance its research and development in the NASH landscape and help its commercialization in the market.
Vaccination 54
54 
Top Life Science News and Trends in 2023 at Xtalks
XTalks
DECEMBER 20, 2023
‘No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness As pharma TV advertising remained popular in 2023, so did partnerships between pharma companies and celebrities for disease and drug campaigns. billion in 2022.
Life Science 59
59 
South African variant may cut response from Pfizer/BioNTech shot, study finds
pharmaphorum
FEBRUARY 18, 2021
The South African coronavirus variant may cut the effectiveness of Pfizer/BioNTech’s vaccine by around two thirds, according to a laboratory study. In a response statement Pfizer and BioNTech noted that the COVID-19 vaccine did still provide protection in the lab study.
Treatment for all: the key steps to better representation in pharma
pharmaphorum
SEPTEMBER 27, 2021
As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. Vaccine hesitancy was the most recent and highest profile example of distrust among minority groups towards the pharmaceutical industry.
Clinical Trials 111
111 
Ocugen gets a black eye as FDA denies emergency OK for COVID jab
pharmaphorum
JUNE 11, 2021
Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of its vaccine candidate. The Russian Sputnik V vaccine was approved for use in India in April. That includes the more transmissible B.1.617.2
Vaccination 62
62 
Why VCs fell in love with pharma R&D in 2021
pharmaphorum
APRIL 5, 2022
And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind.
Pharma R&D 52
52 
Moderna and BioNTech – who are they?
pharmaphorum
DECEMBER 21, 2020
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks Richard Staines. A year ago, the names Moderna and BioNTech were known mainly to those who followed biotech and pharma dealings.
Vaccination 90
90 
Why was R&D productivity up in 2021?
pharmaphorum
FEBRUARY 14, 2022
The easy answer as to why this has happened can be quickly linked to the COVID-19 pandemic, where sales of vaccines and treatments led to a large increase in return on investment and sales projections. This can be understood through the accelerated development cycles experienced on COVID-19 treatments and vaccines.
Production 97
97 
Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’
Drug Discovery World
JANUARY 21, 2024
As a vaccine immunologist Kanekiyo’s primary research interests are structure-based vaccine design, viral immunity, and host-pathogen interplay. As a vaccine immunologist Kanekiyo’s primary research interests are structure-based vaccine design, viral immunity, and host-pathogen interplay.
Protein 52
52 
Neglected tropical diseases: non-profits lead the way as private sectors lags
Pharmaceutical Technology
JUNE 30, 2022
While private pharma companies also take part in such efforts, their efforts has largely been limited to donating assets or distributing treatments. In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals.
Pharma Companies 162
162 
Pfizer drops the blue pill, kicks off 2021 with new DNA logo
pharmaphorum
JANUARY 6, 2021
Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. — Tinglong Dai (@TinglongDai) January 5, 2021.
DNA 116
116 
Why 72% of patients don’t feel listened to by pharma
pharmaphorum
OCTOBER 28, 2020
Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences. “As
Medicine 119
119 
A history of AstraZeneca
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Pharma Companies 116
116 
Should we be worried about pharma’s supply chain?
World of DTC Marketing
APRIL 12, 2021
It’s actually very simple; the more outsourcing in product development and product compounds the greater the risk of a drug failing clinical trials or patients getting a drug that doesn’t meet GMP standards. Why would a pharma company take risks like these? The question that I kept asking was why?
Generic Drugs 187
187 
Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal
pharmaphorum
JULY 5, 2021
The handover comes four years after Pamplona Capital Management bought the company for around $5 billion, and just a few weeks after lab tech company Thermo Fisher Scientific agreed to acquire another CRO – PPD – in a deal valued at $17.4
Let's personalize your content